Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Total Liabilities Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual total liabilities in 2023 was 14.47 Million USD , up 19.68% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly total liabilities in 2024 Q2 was 9.21 Million USD , down -17.62% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported annual total liabilities of 12.09 Million USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total liabilities of 11.18 Million USD for 2024 Q1, down -93.82% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total liabilities of 14.47 Million USD for 2023 FY, up 19.68% from previous quarter.

Annual Total Liabilities Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Total Liabilities of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Total Liabilities Total Liabilities Growth
2023 14.47 Million USD 19.68%
2022 12.09 Million USD 0.0%

Peer Total Liabilities Comparison of Rapport Therapeutics, Inc. Common Stock

Name Total Liabilities Total Liabilities Difference